162 related articles for article (PubMed ID: 16020295)
41. Oxygen dependence of two-photon activation of zinc and copper phthalocyanine tetrasulfonate in Jurkat cells.
Mir Y; van Lier JE; Paquette B; Houde D
Photochem Photobiol; 2008; 84(5):1182-6. PubMed ID: 18331397
[TBL] [Abstract][Full Text] [Related]
42. Photothrombic activity of m-THPC-loaded liposomal formulations: pre-clinical assessment on chick chorioallantoic membrane model.
Pegaz B; Debefve E; Ballini JP; Wagnières G; Spaniol S; Albrecht V; Scheglmann DV; Nifantiev NE; van den Bergh H; Konan-Kouakou YN
Eur J Pharm Sci; 2006 May; 28(1-2):134-40. PubMed ID: 16504490
[TBL] [Abstract][Full Text] [Related]
43. [Photodynamic therapy of pigmented choroidal melanomas in rabbits].
Hu L; Wu X; Song Y; Young LH; Gragoudas ES
Zhonghua Yan Ke Za Zhi; 2002 Aug; 38(8):491-4. PubMed ID: 12410990
[TBL] [Abstract][Full Text] [Related]
44. Synthesis and photodynamic activity of zinc(II) phthalocyanine derivatives bearing methoxy and trifluoromethylbenzyloxy substituents in homogeneous and biological media.
Yslas EI; Rivarola V; Durantini EN
Bioorg Med Chem; 2005 Jan; 13(1):39-46. PubMed ID: 15582450
[TBL] [Abstract][Full Text] [Related]
45. Low-power photodynamic therapy induces survival signaling in perihilar cholangiocarcinoma cells.
Weijer R; Broekgaarden M; van Golen RF; Bulle E; Nieuwenhuis E; Jongejan A; Moerland PD; van Kampen AH; van Gulik TM; Heger M
BMC Cancer; 2015 Dec; 15():1014. PubMed ID: 26705830
[TBL] [Abstract][Full Text] [Related]
46. Mitochondria-dependent apoptosis induced by a novel amphipathic photochemotherapeutic agent ZnPcS2P2 in HL60 cells.
Huang HF; Chen YZ; Wu Y
Acta Pharmacol Sin; 2005 Sep; 26(9):1138-44. PubMed ID: 16115383
[TBL] [Abstract][Full Text] [Related]
47. In vitro evaluation of combined hyperthermia and photodynamic effects using magnetoliposomes loaded with cucurbituril zinc phthalocyanine complex on melanoma.
Bolfarini GC; Siqueira-Moura MP; Demets GJ; Morais PC; Tedesco AC
J Photochem Photobiol B; 2012 Oct; 115():1-4. PubMed ID: 22854225
[TBL] [Abstract][Full Text] [Related]
48. [Experimental assessment of the capacities of use of photosense. Communication 2. Photodynamic therapy for epibulbar and choroid tumors].
Budzinskaia MV; Likhvantseva VG; Shevxchik SA; Loshchenov VB; Kuz'min SG; Vorozhtsov GN
Vestn Oftalmol; 2005; 121(5):17-9. PubMed ID: 16274057
[TBL] [Abstract][Full Text] [Related]
49. [Selective occlusion of ocular neovascularization by photodynamic therapy].
Schmidt U; Birngruber R; Hasan T
Ophthalmologe; 1992 Oct; 89(5):391-4. PubMed ID: 1304219
[TBL] [Abstract][Full Text] [Related]
50. Enhanced photodynamic efficacy of zinc phthalocyanine by conjugating to heptalysine.
Li L; Luo Z; Chen Z; Chen J; Zhou S; Xu P; Hu P; Wang J; Chen N; Huang J; Huang M
Bioconjug Chem; 2012 Nov; 23(11):2168-72. PubMed ID: 23057652
[TBL] [Abstract][Full Text] [Related]
51. In vitro photodynamic inactivation of Cryptococcus neoformans melanized cells with chloroaluminum phthalocyanine nanoemulsion.
Rodrigues GB; Primo FL; Tedesco AC; Braga GU
Photochem Photobiol; 2012; 88(2):440-7. PubMed ID: 22145636
[TBL] [Abstract][Full Text] [Related]
52. Mitotic catastrophe induced in HeLa cells by photodynamic treatment with Zn(II)-phthalocyanine.
Rello-Varona S; Stockert JC; Cañete M; Acedo P; Villanueva A
Int J Oncol; 2008 Jun; 32(6):1189-96. PubMed ID: 18497980
[TBL] [Abstract][Full Text] [Related]
53. Vascular targeting in photodynamic occlusion of subretinal vessels.
Schmidt-Erfurth U; Hasan T; Gragoudas E; Michaud N; Flotte TJ; Birngruber R
Ophthalmology; 1994 Dec; 101(12):1953-61. PubMed ID: 7997334
[TBL] [Abstract][Full Text] [Related]
54. Intravenous repeated-dose toxicity study of ZnPcS2P2-based-photodynamic therapy in Wistar rats.
Zhang Z; Jin H; Bao J; Fang F; Wei J; Wang A
Photochem Photobiol Sci; 2006 Nov; 5(11):1006-17. PubMed ID: 17077896
[TBL] [Abstract][Full Text] [Related]
55. Synthesis, properties, and photodynamic inactivation of Escherichia coli using a cationic and a noncharged Zn(II) pyridyloxyphthalocyanine derivatives.
Scalise I; Durantini EN
Bioorg Med Chem; 2005 Apr; 13(8):3037-45. PubMed ID: 15781413
[TBL] [Abstract][Full Text] [Related]
56. Correlation of real-time haemoglobin oxygen saturation monitoring during photodynamic therapy with microvascular effects and tissue necrosis in normal rat liver.
Woodhams JH; Kunz L; Bown SG; MacRobert AJ
Br J Cancer; 2004 Aug; 91(4):788-94. PubMed ID: 15266317
[TBL] [Abstract][Full Text] [Related]
57. Ultradeformable liposome loaded with zinc phthalocyanine and [Ru(NH.NHq)(tpy)NO]
de Lima RG; Tedesco AC; da Silva RS; Lawrence MJ
Photodiagnosis Photodyn Ther; 2017 Sep; 19():184-193. PubMed ID: 28578126
[TBL] [Abstract][Full Text] [Related]
58. The effect of different liposomal formulations on the interaction of Zn(II)-phthalocyanine with isolated low and high density lipoproteins.
Polo L; Bianco G; Reddi E; Jori G
Int J Biochem Cell Biol; 1995 Dec; 27(12):1249-55. PubMed ID: 8581821
[No Abstract] [Full Text] [Related]
59. Preparation of 100 nm diameter unilamellar vesicles containing zinc phthalocyanine and cholesterol for use in photodynamic therapy.
Oliveira CA; Machado AE; Pessine FB
Chem Phys Lipids; 2005 Jan; 133(1):69-78. PubMed ID: 15589227
[TBL] [Abstract][Full Text] [Related]
60. Nuclear imaging potential and in vitro photodynamic activity of symmetrical and asymmetrical zinc phthalocyanines.
Yurt Lambrecht F; Ocakoglu K; Er O; Ince M; Gunduz C; Kayabası C
J Labelled Comp Radiopharm; 2016 May; 59(5):221-7. PubMed ID: 27059543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
